Tricida (NASDAQ: TCDA)
Some price data may be temporarily unavailable.
Tricida Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Tricida Company Info
Tricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker on May 22, 2013 and is headquartered in South San Francisco, CA.
News & Analysis
Why Tricida Stock Is Jumping Today
The drugmaker announced a stock and warrant offering.
Here's Why Tricida Shares Plummeted Today
The FDA denied the biotech's appeal, but there's still a path forward for its drug.
Here's What Drove Tricida 67% Higher in March
It looks like the company found an easy solution to a big problem.
Why MAG Silver, comScore, and Tricida Slumped Today
Even on a great day on Wall Street, these companies couldn't share in the good news.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.